post-acute COVID-19 syndrome,PACS
Conditions
Interventions
Symptom observation group:none
Intestinal flora observation group:none
Microbiota transplant group:FMT
control group:placebo
Sponsors
The First Hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) 18-65 years old; (2) Refer to the "Diagnosis and Treatment Plan for Novel Coronavirus Pneumonia (Trial Version 9)", confirmed cases of COVID-19 must meet the diagnostic conditions of suspected cases and mild patients with positive new coronavirus nucleic acid test; (3) Fatigue, insomnia and gastrointestinal symptoms at the same time; (4) Subjects voluntarily participate in clinical trials and sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Difficulty swallowing and frequent vomiting; (2) Those with previous history of fatigue, insomnia, and digestive tract; (3) Those who have recently taken antibiotics or used probiotic supplements for a long time; (4) Active malignant tumor; (5) Those who are known to have severe organ failure, immunodeficiency or immunodeficiency; (6) Long-term use of hormones and immunosuppressants; (7) Pregnant and lactating women; (8) Those with mental retardation or inability to provide informed consent; (9) Those who refuse to participate in clinical trials; (10) Other contraindications to flora transplantation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microbiota test results; | — |
Countries
China
Contacts
Public ContactZhaozengren
The First Hospital of Hebei Medical University
Outcome results
None listed